PUE-14202-30514
3 vaccinations
1 coded response
11 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 602 / IL
- Registered
- 2021-02-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-06
Registered in v-safe
-
2021-02-06
Dose 1 — Moderna
-
2021-03-08
Dose 2 — Moderna
-
2021-11-05
Dose 3 — Moderna
- 2021-11-08
- 2021-11-09
- 2021-11-11
- 2021-11-12
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2021-12-10
- 2021-12-17
- 2022-02-04
-
2022-05-06
Survey response — 6 months, dose 3MedDRA: Headache, Nausea, Respiratory tract congestion, Rhinorrhoea, Vomiting — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: nausea, vomiting, headache, runny nose, congestionMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-06 | Moderna | No |
| 2 | 2021-03-08 | Moderna | No |
| 3 | 2021-11-05 | Moderna | No |
Free text
Release 11 — 6 months, dose 3
Symptoms: nausea, vomiting, headache, runny nose, congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release